TXG
TXG
US88025U1097
10x Genomics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 642.823.000 610.785.000
5.2%
Cost of Revenue 198.942.000 196.303.000
1.3%
Gross Profit 443.881.000 414.482.000
7.1%
554.766.000 609.041.000
8.9%
Operating Income -110.885.000 -194.559.000
43.0%
Pretax Income -39.907.000 -177.700.000
77.5%
Net Income Common Stockholders -43.544.000 -182.627.000
76.2%
-- --
--
-- --
--
ende